Bank of New York Mellon Corp - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$8,072,104
-60.7%
861,484
+2.9%
0.00%
-50.0%
Q2 2023$20,531,412
+7.2%
836,992
+1.7%
0.00%0.0%
Q1 2023$19,155,119
-9.5%
823,168
-1.6%
0.00%
-20.0%
Q4 2022$21,169,283
+50.4%
836,400
+14.6%
0.01%
+66.7%
Q3 2022$14,077,000
-21.3%
730,087
+4.0%
0.00%
-25.0%
Q2 2022$17,880,000
+153.3%
701,993
+155.7%
0.00%
+300.0%
Q1 2022$7,060,000
-39.5%
274,503
-1.6%
0.00%
-50.0%
Q4 2021$11,677,000
+2.5%
278,884
+6.5%
0.00%0.0%
Q3 2021$11,392,000
+0.4%
261,752
+9.1%
0.00%0.0%
Q2 2021$11,342,000
+29.2%
239,891
+40.0%
0.00%0.0%
Q1 2021$8,782,000
+80.9%
171,306
-5.5%
0.00%
+100.0%
Q4 2020$4,854,000
-14.3%
181,225
+9.8%
0.00%0.0%
Q3 2020$5,664,000
+11.6%
165,006
+33.3%
0.00%0.0%
Q2 2020$5,073,000
+654.9%
123,830
+531.2%
0.00%
Q1 2020$672,000
+312.3%
19,617
+51.6%
0.00%
Q4 2019$163,00012,9430.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders